Review article
SGLT2i in heart failure: can their benefits be expanded across the entire spectrum of ejection fraction?
Los iSGLT2 en la insuficiencia cardiaca. ¿Sus beneficios pueden extenderse a todo el espectro de la fracción de eyección?
Juan Antonio Requena-Ibáñez
, Carlos G. Santos-Gallego, Juan José Badimón
Corresponding author
Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York City, United States
Read
130
Timeswas read the article
43
Total PDF
87
Total HTML
0
Total EPUB
| Year/Month | Html | Epub | Total | |
|---|---|---|---|---|
| 2023 February | 0 | 0 | 0 | 0 |
| 2023 January | 2 | 4 | 0 | 6 |
| 2022 December | 1 | 0 | 0 | 1 |
| 2022 November | 1 | 3 | 0 | 4 |
| 2022 October | 4 | 2 | 0 | 6 |
| 2022 September | 12 | 4 | 0 | 16 |
| 2022 August | 64 | 20 | 0 | 84 |
| 2022 July | 3 | 10 | 0 | 13 |
